Evidence map›Paper›PMID 21438548›Full record

ArticleJournal of chemical information and modeling2011

Target-specific support vector machine scoring in structure-based virtual screening: computational validation, in vitro testing in kinases, and effects on lung cancer cell proliferation.

Liwei Li, May Khanna, Inha Jo, Fang Wang, Nicole M Ashpole, Andy Hudmon, Samy O Meroueh

Abstract readLetter
In one paragraph

Article in Journal of chemical information and modeling, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Receptor-ligand molecular docking.Biophysical reviews · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Liwei Li
May Khanna
Inha Jo
Fang Wang
Nicole M Ashpole
Andy Hudmon
Samy O Meroueh
Neurosciences Institute · USIndiana University – Purdue University Indianapolis · US

Funding

Small-molecule Inhibition of the Interactions of the Urokinase Receptor: A TargeR01CA135380 · NCI · INDIANA UNIVERSITY INDIANAPOLIS · PI MEROUEH, SAMY · 2009 to 2012
$1.0M
Targeting ALDH2 for Adjuvant Treatment of Alcohol DependenceR21AA019746 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · PI HURLEY, THOMAS D., MEROUEH, SAMY · 2010 to 2011
$416k
NCI NIH HHS CA135380NCI NIH HHS R01 CA135380NIAAA NIH HHS AA019746NIAAA NIH HHS R21 AA019746
6 · The paper itself

Abstract

We assess the performance of our previously reported structure-based support vector machine target-specific scoring function across 41 targets, 40 among them from the Directory of Useful Decoys (DUD). The area under the curve of receiver operating characteristic plots (ROC-AUC) revealed that scoring with SVM-SP resulted in consistently better enrichment over all target families, outperforming Glide and other scoring functions, most notably among kinases. In addition, SVM-SP performance showed little variation among protein classes, exhibited excellent performance in a test case using a homology model, and in some cases showed high enrichment even with few structures used to train a model. We put SVM-SP to the test by virtual screening 1125 compounds against two kinases, EGFR and CaMKII. Among the top 25 EGFR compounds, three compounds (1-3) inhibited kinase activity in vitro with IC₅₀ of 58, 2, and 10 μM. In cell cultures, compounds 1-3 inhibited nonsmall cell lung carcinoma (H1299) cancer cell proliferation with similar IC₅₀ values for compound 3. For CaMKII, one compound inhibited kinase activity in a dose-dependent manner among 20 tested with an IC₅₀ of 48 μM. These results are encouraging given that our in-house library consists of compounds that emerged from virtual screening of other targets with pockets that are different from typical ATP binding sites found in kinases. In light of the importance of kinases in chemical biology, these findings could have implications in future efforts to identify chemical probes of kinases within the human kinome.

Indexed as

Artificial IntelligenceAlgorithmsBinding SitesCalcium-Calmodulin-Dependent Protein Kinase Type 2Carcinoma, Non-Small-Cell LungCell Line, TumorCell ProliferationDrug DiscoveryEnzyme InhibitorsErbB ReceptorsHumansInhibitory Concentration 50Lung NeoplasmsModels, MolecularQuantitative Structure-Activity RelationshipROC CurveCalcium-Calmodulin-Dependent Protein Kinase Type 2EGFR protein, humanEnzyme InhibitorsErbB ReceptorsSmall Molecule Libraries

Identifiers

PMID21438548
PMCPMC3092157
OpenAlexW2001722230

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.